Table 1.

Demographic data of inflammatory SE patients.

	Patients (n = 46)
Onset age (years)	45 (28–60)
Female	25 (54.3)
Onset symptom
Fever	24 (52.2)
Decreased consciousness	17 (37.0)
Seizure	10 (21.7)
Upper respiratory tract infection	8 (17.4)
Headache	6 (13.0)
Psychosis	6 (13.0)
Fatigue	3 (6.5)
Cognitive decline	1 (2.2)
Latency of seizure after onset symptoms (days)	3 (0–7)
STESS ≥3 at admission	18 (39.1)
END-IT score ≥3 at admission	43 (93.5)
SE with prominent motor symptoms	37 (80.4)
Generalized convulsive SE	25 (54.3)
Epilepsia partialis continua	6 (13.0)
Focal onset evolving into bilateral convulsive SE	4 (8.7)
Myoclonic SE with coma	1 (2.2)
Hyperkinetic SE	1 (2.2)
Non-convulsive SE	9 (19.6)
Non-convulsive SE with coma	6 (13.0)
Myoclonic absence status	1 (2.2)
Non-convulsive SE without impairment of consciousness	1 (2.2)
Aphasic status	1 (2.2)
Number of AEDs used	3 (2-3)
Refractory SE	36 (78.3)
Super refractory SE	19 (41.3)
Required general anesthesia for SE control	21 (45.7)
Death during admission	13 (28.3)
Days of admission	39 (26-79)
Days in ICU	33.5 (11-60)
More than two AEDs at discharge	17 (36.9)
Good outcome at discharge (mRS<3)	17 (36.9)
Good outcome at last follow up (mRS<3)	16 (34.8)

Continuous variables were presented as median (interquartile range)

Categorical variables were presented as n (%).

AED, antiepileptic drug; ICU, intensive care unit; mRS, modified Rankin Scale; SE, status epilepticus; STESS, status epilepticus severity score.